1
|
Cormenzana Méndez I, Martín A, O'Donell B, Cao D, Barrionuevo PA. Temporal integration of rod signals in luminance and chromatic pathways. JOURNAL OF THE OPTICAL SOCIETY OF AMERICA. A, OPTICS, IMAGE SCIENCE, AND VISION 2022; 39:1782-1793. [PMID: 36215550 DOI: 10.1364/josaa.462581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Accepted: 08/13/2022] [Indexed: 06/16/2023]
Abstract
We assessed how rod excitation (R) affects luminance (L + M + S) and chromatic [L/(L + M)] reaction times (RTs). A four-primary display based on the overlapped images of two spectrally modified monitors, which allowed specific or combined [L + M + S + R, L/(L + M) + R] photoreceptor stimulation, was used to present a C-target stimulus differing from the background only by the selected stimulation. For the luminance pathway, rod input increased RTs, suggesting a suppressive rod-cone interaction. The responses of the chromatic pathway were faster when rods were involved, suggesting a major role of rods in mesopic color perception.
Collapse
|
3
|
Aleman TS, Miller AJ, Maguire KH, Aleman EM, Serrano LW, O'Connor KB, Bedoukian EC, Leroy BP, Maguire AM, Bennett J. A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene Therapy. Clin Ophthalmol 2021; 15:939-952. [PMID: 33688162 PMCID: PMC7936670 DOI: 10.2147/opth.s292527] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Accepted: 01/22/2021] [Indexed: 12/19/2022] Open
Abstract
Purpose To test the ability of a virtual reality (VR) orientation and mobility (O&M) protocol to serve a measure of functional vision for patients with inherited retinal degenerations (IRDs). Methods A VR-O&M protocol designed using a commercially available VR hardware was tested in normally sighted control subjects (n=7; ages 10–35yo; Average 22.5yo) and patients with RPE65-associated Leber Congenital Amaurosis (n=3; ages 7–18yo; Average 12.7yo), in two of them before and after gene therapy. Patients underwent perimetry and full-field sensitivity testing. VR-O&M parameters correlated with the visual dysfunction. Results Visual acuities in RPE65 patients were on average worse than 20/200, dark-adapted sensitivity losses >5 log units, and fields constricted between 20° and 40°. Before treatment, patients required ~1000-fold brighter environment to navigate, had at least x4 more collisions, and were slower both to orient and navigate compared to control subjects. Improvements in cone- (by 1–2 L.u.) and rod-mediated (by >4 L.u.) sensitivities post-treatment led to fewer collisions (at least by half) at ~100-fold dimmer luminances, and to x4 times faster navigation times. Conclusion This study provides proof-of-concept data in support for the use of VR-O&M systems to quantify the impact that the visual dysfunction and improvement of vision following treatments has on functional vision in IRDs. The VR-O&M was useful in potentially challenging scenarios such as in pediatric patients with severe IRDs. Translational Relevance A VR-O&M test will provide much needed flexibility, both in its deployment as well as in the possibility to test various attributes of vision that may be impacted by gene therapy in the setting of translational studies. Precis This study provides proof-of-concept data in support for the use of a virtual reality orientation and mobility test to quantify the impact of the disease and of treatments thereof on functional vision in inherited retinal degenerations.
Collapse
Affiliation(s)
- Tomas S Aleman
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.,Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA
| | - Alexander J Miller
- Neurology Virtual Reality Laboratory of the Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
| | - Katherine H Maguire
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
| | - Elena M Aleman
- Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
| | - Leona W Serrano
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
| | - Keli B O'Connor
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
| | - Emma C Bedoukian
- Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - Bart P Leroy
- Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.,Department of Pediatrics, Ghent University, Ghent, Belgium.,Department of Ophthalmology, Ghent University, Ghent, Belgium.,Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium
| | - Albert M Maguire
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.,Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA
| | - Jean Bennett
- Scheie Eye Institute at the Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.,Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
4
|
Foutch BK, Bassi CJ. Is the Helmholtz–Kohlrausch Effect More Robust in Women? Perception 2020; 49:636-657. [DOI: 10.1177/0301006620929970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
For gray or achromatic objects, brightness is a relatively simple transformation where very low luminance levels are perceived as black and higher levels are perceived as white. For chromatic objects, the transformation is more complex, depending on color purity as well. This influence of color purity on a color’s perceived brightness is a well-established phenomenon known as the Helmholtz–Kohlrausch (H-K) effect. We investigated gender differences in the H-K effect by measuring brightness (via direct brightness matching [DBM]) and luminance (via heterochromatic flicker photometry [HFP]) at five wavelengths (450, 520, 560, 580, and 650 nm) perceived as blue, green, green-yellow, yellow, and red hues. We compared DBM/HFP ratios between 13 males and 18 females. Based on previous evidence of a female advantage in chromatic processes, we hypothesized that DBM/HFP ratios would be higher in female subjects. While HFP measures were essentially the same between male and female subjects, DBM measures and DBM/HFP ratios were significantly higher for female subjects than males. There were no significant effects of contraceptive use based on a post hoc comparison. We also derived simple models of brightness as a function of luminance and saturation, which further suggest gender dimorphism in the H-K effect.
Collapse
Affiliation(s)
- Brian K. Foutch
- Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, Texas, United States
| | - Carl J. Bassi
- College of Optometry, University of Missouri-St. Louis, St. Louis, Missouri, United States
| |
Collapse
|
5
|
Huchzermeyer C, Fars J, Kremers J. Photoreceptor-Specific Loss of Perifoveal Temporal Contrast Sensitivity in Retinitis Pigmentosa. Transl Vis Sci Technol 2020; 9:27. [PMID: 32821524 PMCID: PMC7409023 DOI: 10.1167/tvst.9.6.27] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Accepted: 04/01/2020] [Indexed: 02/07/2023] Open
Abstract
Purpose Inherited retinal diseases affect the L-, M-, S-cones and rods in distinct ways, which calls for new methods that enable quantification of photoreceptor-specific functions. We tested the feasibility of using the silent substitution paradigm to estimate photoreceptor-driven temporal contrast sensitivity (tCS) functions in patients with retinitis pigmentosa. Methods The silent substitution paradigm is based on substitution of lights of different spectral composition; this offers considerable advantage over other stimulation techniques. We used a four-primary LED stimulator to create perifoveal annular stimuli (2° inner, 12° outer diameters) and used a triple silent substitution to probe photoreceptor-selective tCS. Measurements were performed in a heterogeneous cohort of 15 patients with retinitis pigmentosa and related to those in a control group of nine color-normal healthy observers. Age differences between groups were addressed with a model of age-related normal contrast sensitivity derived from measurements in 20 healthy observers aged between 23 and 83 years. Results The age-related loss of tCS amounted to 0.1 dB/year in healthy subjects across all photoreceptor subtypes. In patients, tCS was decreased for every photoreceptor subtype; however, S-cone- and rod-driven sensitivities were most strongly affected. Postreceptoral mechanisms were not affected. Conclusions This feasibility study provides evidence that the silent substitution technique enables the estimation of photoreceptor-selective tCS functions and can serve as an accurate biomarker of photoreceptor-specific contrast sensitivity loss in patients with retinitis pigmentosa. Translational Relevance We aim to develop tests of visual function for clinical trials of novel therapies for inherited retinal diseases from methods that can currently be used only in vision research labs.
Collapse
Affiliation(s)
- Cord Huchzermeyer
- Department of Ophthalmology, University Hospital Erlangen, Erlangen, Germany
| | - Julien Fars
- Department of Ophthalmology, University Hospital Erlangen, Erlangen, Germany
| | - Jan Kremers
- Department of Ophthalmology, University Hospital Erlangen, Erlangen, Germany
| |
Collapse
|
7
|
Tikidji-Hamburyan A, Reinhard K, Storchi R, Dietter J, Seitter H, Davis KE, Idrees S, Mutter M, Walmsley L, Bedford RA, Ueffing M, Ala-Laurila P, Brown TM, Lucas RJ, Münch TA. Rods progressively escape saturation to drive visual responses in daylight conditions. Nat Commun 2017; 8:1813. [PMID: 29180667 PMCID: PMC5703729 DOI: 10.1038/s41467-017-01816-6] [Citation(s) in RCA: 68] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Accepted: 10/18/2017] [Indexed: 12/21/2022] Open
Abstract
Rod and cone photoreceptors support vision across large light intensity ranges. Rods, active under dim illumination, are thought to saturate at higher (photopic) irradiances. The extent of rod saturation is not well defined; some studies report rod activity well into the photopic range. Using electrophysiological recordings from retina and dorsal lateral geniculate nucleus of cone-deficient and visually intact mice, we describe stimulus and physiological factors that influence photopic rod-driven responses. We find that rod contrast sensitivity is initially strongly reduced at high irradiances, but progressively recovers to allow responses to moderate contrast stimuli. Surprisingly, rods recover faster at higher light levels. A model of rod phototransduction suggests that phototransduction gain adjustments and bleaching adaptation underlie rod recovery. Consistently, exogenous chromophore reduces rod responses at bright background. Thus, bleaching adaptation renders mouse rods responsive to modest contrast at any irradiance. Paradoxically, raising irradiance across the photopic range increases the robustness of rod responses. Rod photoreceptors are thought to be saturated under bright light. Here, the authors describe the physiological parameters that mediate response saturation of rod photoreceptors in mouse retina, and show that rods can drive visual responses in photopic conditions.
Collapse
Affiliation(s)
- Alexandra Tikidji-Hamburyan
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany.,International Max Planck Research School, University of Tübingen, 72074, Tübingen, Germany.,Department of Neurosurgery and Hansen Experimental Physics Laboratory, Stanford University, Stanford, California, 94305-4085, USA
| | - Katja Reinhard
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany.,International Max Planck Research School, University of Tübingen, 72074, Tübingen, Germany.,Visual Circuits Laboratory, Neuro-Electronics Research Flanders, IMEC, KU Leuven and VIB, 3001, Leuven, Belgium
| | - Riccardo Storchi
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - Johannes Dietter
- Institute for Ophthalmic Research, Department of Ophthalmology, University of Tübingen, 72076, Tübingen, Germany
| | - Hartwig Seitter
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany.,International Max Planck Research School, University of Tübingen, 72074, Tübingen, Germany.,Institute of Pharmacy, Department of Pharmacology and Toxicology, University of Innsbruck, A-6020, Innsbruck, Austria
| | - Katherine E Davis
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - Saad Idrees
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany.,International Max Planck Research School, University of Tübingen, 72074, Tübingen, Germany
| | - Marion Mutter
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany.,International Max Planck Research School, University of Tübingen, 72074, Tübingen, Germany
| | - Lauren Walmsley
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - Robert A Bedford
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.,Stryker Imorphics, Worthington House, Towers Business Park, Wilmslow Road, Manchester, M20 2HJ, UK
| | - Marius Ueffing
- Institute for Ophthalmic Research, Department of Ophthalmology, University of Tübingen, 72076, Tübingen, Germany
| | - Petri Ala-Laurila
- Department of Biosciences, University of Helsinki, 00014, Helsinki, Finland.,Department of Neuroscience and Biomedical Engineering (NBE), Aalto University School of Science and Technology, 00076, Espoo, Finland
| | - Timothy M Brown
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - Robert J Lucas
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
| | - Thomas A Münch
- Retinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, 72076, Tübingen, Germany. .,Institute for Ophthalmic Research, Department of Ophthalmology, University of Tübingen, 72076, Tübingen, Germany.
| |
Collapse
|